Structural determinants of 5-HT2B receptor activation and biased agonism-Reference-Cited by-同舟云学术

Structural determinants of 5-HT2B receptor activation and biased agonism

Published:2018-08-20 Issue:9 Volume:25 Page:787-796
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

McCorvy John D.^ORCID,Wacker Daniel,Wang Sheng^ORCID,Agegnehu Bemnat,Liu Jing^ORCID,Lansu Katherine,Tribo Alexandra R.,Olsen Reid H. J.,Che Tao,Jin Jian^ORCID,Roth Bryan L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/s41594-018-0116-7.pdf

Reference47 articles.

1. Berger, M., Gray, J. A. & Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 60, 355–366 (2009).

2. McCorvy, J. D. & Roth, B. L. Structure and function of serotonin G protein–coupled receptors. Pharmacol. Ther. 150, 129–142 (2015).

3. Allen, J. A. & Roth, B. L. Strategies to discover unexpected targets for drugs active at G protein–coupled receptors. Annu. Rev. Pharmacol. Toxicol. 51, 117–144 (2011).

4. Vickers, S. P., Clifton, P. G., Dourish, C. T. & Tecott, L. H. Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor–mutant mice. Psychopharmacology 143, 309–314 (1999).

5. Roth, B. L. Drugs and valvular heart disease. N. Engl. J. Med. 356, 6–9 (2007).

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ligand bias at the muscarinic acetylcholine receptor family: Opportunities and challenges;Neuropharmacology;2024-11

2. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

3. Conformational dynamics underlying atypical chemokine receptor 3 activation;Proceedings of the National Academy of Sciences;2024-07-15

4. GOLEM: Automated and Robust Cryo-EM-Guided Ligand Docking with Explicit Water Molecules;Journal of Chemical Information and Modeling;2024-07-11

5. Uncovering the unique characteristics of different groups of 5-HT5AR ligands with reference to their interaction with the target protein;Pharmacological Reports;2024-07-06